This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The new recommendation supports the use of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in the European Union (EU). Results from the ARANOTE trial show darolutamide plus ADT significantly reduces the risk of radiological progression or death.
Hormonal Status : A body’s hormones, such as levels of reproductive hormones and thyroid function, can impact tissue responses to radiation therapy. It also oversees Good Manufacturing Practices (GMP) for radiopharmaceutical production facilities to ensure consistent quality and safety standards.
Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.
Advise patients of these risks and the need for effective non-hormonal contraception. WELIREG can render some hormonal contraceptives ineffective. Merck is working to optimize production of WELIREG to allow for a sustainable supply to meet anticipated U.S. WELIREG can render some hormonal contraceptives ineffective.
Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist. To overcome this, Glucagon, a hormone in the body, helps the liver to quickly increase blood sugar levels. Teleflex Incorporated has finally completed the acquisition of Z-Medica, an industry-leading manufacturer of hemostatic products.
Before COVID, the UK spent £12 per head on IVD products – around half that of Germany and two thirds of France – according to MedTech Europe. Again, before the pandemic, the UK carried out around 900 million tests each year and was a net exporter of IVD products. However, COVID has been a game-changer in more ways than one.
Symptoms may include hypoxia, cough, dyspnea, or interstitial infiltrates on radiologic exams. There are no data on the presence of Verzenio in human milk or its effects on the breastfed child or on milk production. Patients should avoid grapefruit products. Monitor patients for pulmonary symptoms indicative of ILD/pneumonitis.
Rujin Ju, MD, MSCR, FACOG, Medical Director of the Medical Department, Women’s Health at Medpace, who discussed innovation in women’s health clinical research and FemTech — innovative technology-based products and services designed to address women’s health issues. Defining women’s health — Medpace’s diverse therapeutic expertise.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content